Suppr超能文献

高通量药物筛选中的汇集

Pooling in high-throughput drug screening.

作者信息

Kainkaryam Raghunandan M, Woolf Peter J

机构信息

Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.

出版信息

Curr Opin Drug Discov Devel. 2009 May;12(3):339-50.

Abstract

Pooling in HTS refers to the act of testing mixtures of compounds in a primary screen to accurately identify hits for secondary screening. The reduction in the number of tests needed to screen a compound library by pooling can also be extended to achieve much-needed error tolerance in HTS. Despite the success of HTS in other biological experiments, pooling in high-throughput drug screening has been a controversial and often marginalized paradigm. At first appearance, pooling appears to promise gains from reduced effort, or possibly could create more problems than solutions. However, this article demonstrates that pooling is a practical and necessary part of HTS: discussions include the rationale for pooling compounds in HTS, a unifying view of pooling design theory, a review of past attempts at pooling and their success, and recent advances in the field.

摘要

高通量筛选(HTS)中的混合指的是在初次筛选中对化合物混合物进行测试,以准确识别用于二次筛选的活性物质。通过混合来筛选化合物库所需测试次数的减少,也可用于在高通量筛选中实现急需的容错能力。尽管高通量筛选在其他生物学实验中取得了成功,但在高通量药物筛选中,混合一直是一个有争议且常被边缘化的模式。乍一看,混合似乎有望通过减少工作量而有所收获,或者可能带来的问题比解决的问题更多。然而,本文表明混合是高通量筛选中切实可行且必要的一部分:讨论内容包括在高通量筛选中混合化合物的基本原理、混合设计理论的统一观点、对过去混合尝试及其成功情况的回顾,以及该领域的最新进展。

相似文献

1
Pooling in high-throughput drug screening.
Curr Opin Drug Discov Devel. 2009 May;12(3):339-50.
2
poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.
BMC Bioinformatics. 2008 May 30;9:256. doi: 10.1186/1471-2105-9-256.
3
Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality.
J Biomol Screen. 2015 Jun;20(5):577-87. doi: 10.1177/1087057115572988. Epub 2015 Feb 26.
5
Screening Pools of Compounds against Multiple Endogenously Expressed Targets in a Chemoproteomics Binding Assay.
J Lab Autom. 2016 Feb;21(1):133-42. doi: 10.1177/2211068215595355. Epub 2015 Jul 13.
6
Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Anal Chem. 2007 Nov 1;79(21):8207-13. doi: 10.1021/ac062421q. Epub 2007 Sep 29.
8
Molecular library design using multi-objective optimization methods.
Methods Mol Biol. 2011;685:53-69. doi: 10.1007/978-1-60761-931-4_3.
9
Technological advances in high-throughput screening.
Am J Pharmacogenomics. 2004;4(4):263-76. doi: 10.2165/00129785-200404040-00006.
10
Novel miniaturized systems in high-throughput screening.
Trends Biotechnol. 2002 Apr;20(4):167-73. doi: 10.1016/s0167-7799(01)01898-4.

引用本文的文献

1
Uncovering Novel Drugs that Restore Vision Using Orthogonal Pooling in Zebrafish.
Adv Exp Med Biol. 2025;1468:491-495. doi: 10.1007/978-3-031-76550-6_80.
2
Scalable, compressed phenotypic screening using pooled perturbations.
Nat Biotechnol. 2024 Oct 7. doi: 10.1038/s41587-024-02403-z.
3
MultiplexMS: A Mass Spectrometry-Based Multiplexing Strategy for Ultra-High-Throughput Analysis of Complex Mixtures.
Anal Chem. 2023 Aug 15;95(32):11908-11917. doi: 10.1021/acs.analchem.3c00939. Epub 2023 Aug 2.
4
Evaluation of a Pooling Chemoproteomics Strategy with an FDA-Approved Drug Library.
Biochemistry. 2023 Feb 7;62(3):624-632. doi: 10.1021/acs.biochem.2c00256. Epub 2022 Aug 15.
5
Capturing the pool dilution effect in group testing regression: A Bayesian approach.
Stat Med. 2022 Oct 15;41(23):4682-4696. doi: 10.1002/sim.9532. Epub 2022 Jul 25.
6
Synergizing the potential of bacterial genomics and metabolomics to find novel antibiotics.
Chem Sci. 2021 Mar 29;12(17):5994-6010. doi: 10.1039/d0sc06919a.
7
When to use one-dimensional, two-dimensional, and Shifted Transversal Design pooling in mycotoxin screening.
PLoS One. 2020 Aug 5;15(8):e0236668. doi: 10.1371/journal.pone.0236668. eCollection 2020.
8
Phenotypic Screening in as a Tool for the Discovery of New Geroprotective Drugs.
Pharmaceuticals (Basel). 2020 Jul 25;13(8):164. doi: 10.3390/ph13080164.
9
Creating and screening natural product libraries.
Nat Prod Rep. 2020 Jul 1;37(7):893-918. doi: 10.1039/c9np00068b. Epub 2020 Mar 18.
10
The objective function controversy for group testing: Much ado about nothing?
Stat Med. 2019 Oct 30;38(24):4912-4923. doi: 10.1002/sim.8341. Epub 2019 Aug 30.

本文引用的文献

1
A positive detecting code and its decoding algorithm for DNA library screening.
IEEE/ACM Trans Comput Biol Bioinform. 2009 Oct-Dec;6(4):652-66. doi: 10.1109/TCBB.2007.70266.
2
High throughput screening. Methods and protocols, second edition. Preface.
Methods Mol Biol. 2009;565:v-vii. doi: 10.1007/978-1-60327-258-2.
3
Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases.
Assay Drug Dev Technol. 2008 Jun;6(3):395-405. doi: 10.1089/adt.2007.110.
4
poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.
BMC Bioinformatics. 2008 May 30;9:256. doi: 10.1186/1471-2105-9-256.
5
Interpool: interpreting smart-pooling results.
Bioinformatics. 2008 Mar 1;24(5):696-703. doi: 10.1093/bioinformatics/btn001. Epub 2008 Jan 9.
6
Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures.
J Med Chem. 2006 Apr 6;49(7):2151-4. doi: 10.1021/jm060029z.
7
Statistical practice in high-throughput screening data analysis.
Nat Biotechnol. 2006 Feb;24(2):167-75. doi: 10.1038/nbt1186.
8
A new pooling strategy for high-throughput screening: the Shifted Transversal Design.
BMC Bioinformatics. 2006 Jan 19;7:28. doi: 10.1186/1471-2105-7-28.
10
Systematic discovery of multicomponent therapeutics.
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7977-82. doi: 10.1073/pnas.1337088100. Epub 2003 Jun 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验